Green Cross Cell corporation (KOSDAQ:A031390) agreed to acquire additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd. (TSE:5901) on March 22, 2018. Green Cross Cell corporation will acquire 59,251 shares in Lymphotec, Inc. After the deal, Green Cross will hold 83.3% stake in Lymphotec from 14.5% stake earlier. Deal is expected to complete by April 2, 2018.

Green Cross Cell corporation (KOSDAQ:A031390) completed the acquisition of additional 68.8% stake in Lymphotec, Inc. from Toyo Seikan Group Holdings, Ltd. (TSE:5901) in April 2018.